Benlysta Drug Interactions
Currently displaying a list of 248 drugs known to interact with Benlysta (belimumab).
- 44 major drug interactions
- 195 moderate drug interactions
- 9 minor drug interactions
Medications known to interact with Benlysta
Note: Showing generic names only.
A
- abatacept
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- ado-trastuzumab emtansine
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- ashwaganda
- atezolizumab
- avelumab
- axicabtagene ciloleucel
- azathioprine
B
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- belantamab mafodotin
- bevacizumab
- bifidobacterium infantis
- bifidobacterium longum
- bimekizumab
- blinatumomab
- bortezomib
- brentuximab
- brewer's yeast
- brexucabtagene autoleucel
- brodalumab
C
- canakinumab
- candida albicans extract
- carfilzomib
- cat's claw
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cladribine
- coccidioidin skin test
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crovalimab
D
- daclizumab
- daratumumab
- dengue vaccine
- denosumab
- deucravacitinib
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- dostarlimab
- durvalumab
E
- echinacea
- eculizumab
- efalizumab
- efgartigimod alfa
- elderberry
- elotuzumab
- elranatamab
- emapalumab
- enfortumab vedotin
- epcoritamab
- etanercept
- etrasimod
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
I
- ibritumomab
- ibrutinib
- idecabtagene vicleucel
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- interferon beta-1a
- interferon beta-1b
- interferon gamma-1b
- iodine i 131 tositumomab
- ipilimumab
- isatuximab
- ixazomib
- ixekizumab
J
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- lifileucel
- lisocabtagene maraleucel
- loncastuximab tesirine
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mirikizumab
- mixed respiratory vaccine
- mogamulizumab
- monomethyl fumarate
- mosunetuzumab
- moxetumomab pasudotox
- mumps skin test antigen
- mumps virus vaccine
N
O
P
- pembrolizumab
- penpulimab
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- polatuzumab vedotin
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponesimod
- pozelimab
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ravulizumab
- retifanlimab
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib topical
S
- saccharomyces boulardii lyo
- sacituzumab govitecan
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) nvx-cov2705 vaccine, adjuvanted
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- siltuximab
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- spesolimab
- staphage lysate (spl)
- streptococcus salivarius
- sutimlimab
T
- tacrolimus topical
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tarlatamab
- teclistamab
- teplizumab
- teriflunomide
- tetanus toxoid
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tislelizumab
- tisotumab vedotin
- tocilizumab
- tofacitinib
- toripalimab
- tositumomab
- trastuzumab
- tremelimumab
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
Y
Z
- zanubrutinib
- zinc acetate
- zinc chloride
- zinc gluconate
- zinc sulfate
- ziv-aflibercept
- zoster vaccine live
- zoster vaccine, recombinant
Benlysta disease interactions
There are 3 disease interactions with Benlysta (belimumab) which include:
Report options
QR code containing a link to this page
More about Benlysta (belimumab)
- Benlysta consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (64)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lupkynis
Lupkynis is used to treat active lupus nephritis in adults with SLE. Lupkynis for lupus is a ...
Reviews & ratings
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Reviews & ratings
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Reviews & ratings
Afinitor Disperz
Afinitor Disperz is used for subependymal giant cell astrocytoma, tuberous sclerosis complex
Reviews & ratings
Arava
Arava (leflunomide) is used to treat the symptoms of rheumatoid arthritis and help reduce joint ...
Reviews & ratings
Arzerra
Arzerra is used to treat chronic lymphocytic leukemia (CLL), usually in combination with other ...
Reviews & ratings
Aubagio
Aubagio (teriflunomide) is used to reduce flare-ups in people with relapsing multiple sclerosis ...
Reviews & ratings
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
